Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation

Bone Marrow Transplantation

Volumn 27, Issue 7, 2001, Pages 761-765

  Haut, P R ^a   Kovarik, P ^b   Shaw, P H ^c   Walterhouse, D ^a   Jenson, H B ^d   Kletzel, M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

EBV; PTLD; Transplant; Umbilical cord blood

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIBIOTIC AGENT; CEFPROZIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD DONOR; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DEATH; DOSE RESPONSE; DRUG MEGADOSE; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WHOLE BODY RADIATION;

B-LYMPHOCYTES; BLOOD DONORS; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 0035038235     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702770     Document Type: Article

References (27)

1. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers
2. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia
3. Malignant neoplasms following bone marrow transplantation
4. Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements
5. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction
6. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique
7. Characterization of β-thalassemia mutations using direct sequencing of amplified single copy DNA
8. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS
9. Risk of lyphoproliferative disorders after bone marrow transplantation: A multi-institutional study
10. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
11. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes
12. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative transplant recipients
13. Therapy for transplant-related lymphoproliferative diseases
14. Aggressive treatment for post cardiac transplant lymphoproliferation
15. Epstein-Barr virus induced lymphoproliferation. Implications for antiviral chemotherapy
16. Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin
17. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndromes following bone marrow and organ transplantation
18. Treatment of severe Epstein-Barr virus induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation
19. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hematopoietic stem-cell transplantation
20. Use of gene modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
21. Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts
22. Immunodeficiency states and related malignancies
23. Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs
24. A re-examination of the Epstein-Barr carrier state in healthy seropositive individuals
25. Infection during pregnancy and congenital infection with Epstein-Barr virus
26. Perinatal Epstein-Barr virus infection in a premature infant
27. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation